1. Pilarski R. Cowden syndrome: a critical review of the clinical literature. J Genet Couns. 2009; 18:13–27.
2. Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res. 2012; 18:400–407.
3. Jung MH. Breast cancer in Cowden cyndrome: a case report. J Korean Soc Radiol. 2009; 60:279–282.
4. Daly MB, Axilbund JE, Buys S, Crawford B, Farrell CD, Friedman S, et al. Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw. 2010; 8:562–594.
5. Sabaté JM, Gómez A, Torrubia S, Blancas C, Sánchez G, Alonso MC, et al. Evaluation of breast involvement in relation to Cowden syndrome: a radiological and clinicopathological study of patients with PTEN germ-line mutations. Eur Radiol. 2006; 16:702–706.
6. Hobert JA, Eng C. PTEN hamartoma tumor syndrome: an overview. Genet Med. 2009; 11:687–694.
7. Bubien V, Bonnet F, Brouste V, Hoppe S, Barouk-Simonet E, David A, et al. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. J Med Genet. 2013; 50:255–263.
8. Lloyd KM 2nd, Dennis M. Cowden's disease. A possible new symptom complex with multiple system involvement. Ann Intern Med. 1963; 58:136–142.
9. Eng C. PTEN hamartoma syndrome. GeneReview at GeneTests: Medical Genetics Information Resource. Updated January 23, 2014. Accessed March 19, 2014.
http://www.genetests.org.
10. Melbārde-Gorkuša I, Irmejs A, Bērziņa D, Strumfa I, Aboliņš A, Gardovskis A, et al. Challenges in the management of a patient with Cowden syndrome: case report and literature review. Hered Cancer Clin Pract. 2012; 10:5.
11. Tan WH, Baris HN, Burrows PE, Robson CD, Alomari AI, Mulliken JB, et al. The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management. J Med Genet. 2007; 44:594–602.
12. Turnbull MM, Humeniuk V, Stein B, Suthers GK. Arteriovenous malformations in Cowden syndrome. J Med Genet. 2005; 42:e50.